Related Experiment Videos
Genitourinary rhabdomyosarcoma in children
K R Loughlin1, A B Retik, H J Weinstein
1Department of Surgery, Children's Hospital, Boston, MA 02115.
Cancer
|April 15, 1989
Summary
Genitourinary rhabdomyosarcoma in children is rare but challenging. Paratesticular tumors show the best survival rates, while bladder/prostate tumors require innovative treatments beyond current standards.
Area of Science:
- Pediatric Oncology
- Surgical Oncology
- Radiation Oncology
Background:
- Genitourinary rhabdomyosarcoma is an uncommon pediatric malignancy.
- This tumor presents significant therapeutic challenges for multidisciplinary teams.
Purpose of the Study:
- To review treatment outcomes for children with genitourinary rhabdomyosarcoma.
- To identify prognostic factors and evaluate treatment strategies.
Main Methods:
- Retrospective analysis of 36 children treated between 1957 and 1985.
- Treatment modalities included surgery, chemotherapy, and radiation therapy.
Main Results:
- Overall event-free survival was 74%.
- Paratesticular tumors had the best prognosis (88% event-free survival), with negative retroperitoneal lymph nodes obviating regional radiation.
- Bladder/prostate tumors had lower survival and functional outcomes, with conservative surgery often compromising bladder integrity.
Conclusions:
- Paratesticular rhabdomyosarcoma has a favorable prognosis with appropriate management.
- Current multimodal therapy is insufficient for bladder/prostate rhabdomyosarcoma, necessitating novel therapeutic approaches.